ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: SA-PO1077

A Proposal of Modified Berden’s Classification of ANCA-Associated Glomerulonephritis Focusing on a Proportion of Active Crescents for an Appropriate Treatment

Session Information

Category: Pathology and Lab Medicine

  • 1502 Pathology and Lab Medicine: Clinical


  • Ogawa, Yayoi, Hokkaido Renal Pathology Center, Sapporo, Japan
  • Kobayashi, Takahisa, Jichi Medical University, Shimotsuke, Tochigi, Japan
  • Nagata, Daisuke, Jichi Medical University, Shimotsuke, Tochigi, Japan
  • Yumura, Wako, Department of nephrology, International University of Health and Welfare Hospital, Nasushiobara, Japan
  • Joh, Kensuke, Tohoku University Graduate School of Medicine, Sendai-city, Japan

In 2010, Berden et al. proposed the histological classification of ANCA-associated glomerulonephritis and categorized sclerotic(S), focal(F), crescentic(C), and mixed (M) classes. The validation studies confirmed the best renal prognosis for F and the worst for S. However, the results of C and M were inconsistent. Therefore, we modified the Berden’s classification by focusing on a pure proportion of active crescents in each C and M from a view point of a further choice of therapy and analyzed the correlation between these subclasses and renal prognosis.


The 35 patients with MPO-ANCA-associated glomerulonephritis (male 57%, 68±7.8 yrs), who were followed more than 5 years, were analyzed. E-GFR at entry was 23.7±21.7ml/min per 1.73m2. In the modified classification, at the first step. S, F and C or M were categorized according to the Berden’s original classification. At the second step, in the category of C or M, New Crescent class (NC) was categorized by active crescents with more than 50% after eliminating global sclerosis and the rest were categorized as New Mixed class (NM), because the global sclerosis in the category of C or M did not respond to the immunosuppressive therapy. In each category, cumulative risk of ESRD (0-5 yrs) and ΔeGFR or ΔCr (serum creatinine) (0-5 yrs) were evaluated


F: C: M: S were 13:5:9:8 respectively, whereas F: NC: NM: S were 13:7:7:8 respectively. Cumulative risk of ESRD (0-5 yrs) showed that F and S revealed best and worst prognosis, respectively (log rank p<0.05). C and M were in the middle, and the prognoses of C and M were not significantly different. However, NC and NM showed significant difference for ΔeGFR (0-5 yrs) and ΔCr (0-5 yrs) . A significant cut off point of a percent of active crescent for ΔeGFR (0-5 yrs) was 50% but not 25% or 75%. Therefore, NC showed a significant better eGFR-improvement than that of NM (p<0.05) indicating a better response to immunosuppressive therapy.


A modified Berden’s classification showed clear discrimination between NC and NM and can propose an appropriate rationale for a further choice of immunosuppressive therapy.